fbpx
Published in Health Care

MiBiz on WOOD-TV8: Generic drug maker developing low-cost insulin

BY Monday, March 28, 2022 02:49pm

With the financial backing of several Michigan-based health care companies, generic drug manufacturer CivicaRx is preparing to produce low-cost insulin within the next two years.

The company is building a new facility in Virginia to produce low-cost generic insulin doses as federal and state lawmakers’ attempts to pass legislation curbing increasingly high costs continue to stall, as Senior Writer Mark Sanchez reported this week.

CivicaRx’s efforts are seen as a private-sector solution to escalating insulin prices that could help drive down costs through competition among manufacturers, MiBiz Managing Editor Andy Balaskovitz discussed today on WOOD-TV8’s “Daybreak” program.

Read 719 times Last modified on Monday, 28 March 2022 19:02
SUBSCRIBE TO MIBIZ TODAY FOR WEST MICHIGAN’S FINEST BUSINESS NEWS REPORTING >